ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1057

Leveraging Social Risk Factor Screening Infrastructure in Rheumatology Clinics to Respond to Rising Rates of Tuberculosis Among Individuals Experiencing Homelessness

Rebecca Summit1, Dylan Tierney2, Taussia Boadi2, Tyler Green2, Karli Retzel2, Virginia Bills2, Nancy Shadick2, Leah Santacroce3, Sara Schoenfeld4 and Candace Feldman5, 1Brigham & Women's Hospital, Boston, MA, 2Brigham & Women's Hospital, Boston, 3Brigham and Women's Hospital, Boston, MA, 4Mass General Hospital, Boston, 5Brigham and Women's Hospital/ Harvard Medical School, Boston

Meeting: ACR Convergence 2025

Keywords: Disparities, psychosocial factors, socioeconomic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1055–1087) Healthcare Disparities in Rheumatology Posters

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Social risk factors, such as housing instability, influence care access and outcomes in people with rheumatic conditions. In June 2022, 9 rheumatology clinics in a multihospital medical center began to screen patients for social risk factors. In September 2024, the Massachusetts Department of Public Health issued an alert of increased tuberculosis (TB) in Boston homeless shelters. Patients with systemic rheumatic conditions have higher TB infection risk and poorer outcomes; immunosuppressive medications heighten risk. We aimed to leverage the social risk screening infrastructure to rapidly respond to TB spread among homeless individuals with rheumatic conditions.

Methods: Using the Research Patient Data Registry and manual electronic health record (EHR) review, we identified patients with >1 ICD-9/10 code for a systemic rheumatic condition receiving >1 immunosuppressive or immunomodulatory medication who indicated that they did not have housing, lived in a shelter, or on the street on their most recent social risk screening. The rheumatology-based social risk screening team met with infectious disease (ID) specialists to develop protocols, and we alerted rheumatologists of patients at high risk for TB with a description of their patients’ risk factors, and instructions to screen for active and latent TB. We reviewed the EHR to determine provider response (Figure 1). If no action was taken, we sent a reminder. The EHR was reviewed after 2 months. Rheumatologists were surveyed for feedback.

Results: Thirty-three patients with systemic rheumatic conditions experienced housing instability. Of these, 23 (70%) patients cared for by 17 rheumatologists were prescribed >1 immunosuppressive or immunomodulatory medication (Table 1). After the first alert, 3 (13%) patients had documentation of TB symptom screening, one provider responded that their patient was not homeless, and one ordered an interferon-gamma release assay (“T-SPOT”). Providers for two (9%) patients prescribed hydroxychloroquine were notified in case there was a therapy escalation plan, but a reminder was not sent due to lower risk. After the second alert, 7 (30%) T-SPOT tests were ordered. One patient self-reported a negative T-SPOT. Four (17%) patients had EHR documentation of symptom review at their subsequent rheumatology appointment, and 3 (13%) patients were messaged about their TB risk. Two (9%) patients had chest imaging ordered. There were no referrals to ID and no action taken for 4 patients. Among the 41 rheumatologists who responded to the survey, 18 (45%) received an alert for >1 patient. Of those, 4 (22%) found it somewhat helpful, 5 (28%) found it very helpful and 16 (89%) indicated that the alert prompted action.

Conclusion: The social risk screening infrastructure in rheumatology facilitated a rapid response to a public health concern. Rheumatologists’ responses varied, possibly due to increased clinical stressors with limited support. While there were challenges reaching patients with social risk factors, actions were taken for most. Efforts are now underway to prompt yearly TB screening for patients who indicate housing instability.

Supporting image 1

Supporting image 2


Disclosures: R. Summit: None; D. Tierney: Compugen, 12, Stock holder, Renovaro, 12, Stock holder, Seres, 12, Stock holder, Viatris, 12, Stock holder; T. Boadi: None; T. Green: None; K. Retzel: None; V. Bills: None; N. Shadick: Bristol-Myers Squibb(BMS), 5, Janssen, 5; L. Santacroce: None; S. Schoenfeld: None; C. Feldman: American College of Rheumatology, 2, 12, Committee Member/Interim Chair, Arthritis Foundation, 5, 12, Task Force Member, Bristol-Myers Squibb Foundation, 5, Harvard Pilgrim, 2, Lupus Foundation of America, 2, 12, Associate Editor, Medical-Scientific Advisory Board Member, OM1, Inc., 2.

To cite this abstract in AMA style:

Summit R, Tierney D, Boadi T, Green T, Retzel K, Bills V, Shadick N, Santacroce L, Schoenfeld S, Feldman C. Leveraging Social Risk Factor Screening Infrastructure in Rheumatology Clinics to Respond to Rising Rates of Tuberculosis Among Individuals Experiencing Homelessness [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/leveraging-social-risk-factor-screening-infrastructure-in-rheumatology-clinics-to-respond-to-rising-rates-of-tuberculosis-among-individuals-experiencing-homelessness/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/leveraging-social-risk-factor-screening-infrastructure-in-rheumatology-clinics-to-respond-to-rising-rates-of-tuberculosis-among-individuals-experiencing-homelessness/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology